CanaMed Melatonin 3 mg Sublingual Tablet
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Animaux autre que l'humain non susceptibles à l' EST - Corps pinéal | 3 milligramme | Not calculated |
Non-medicinal ingredients
D-Mannitol, Dioxyde de silicium, Stéarate de magnésium, Croscarmellose de sodium, Acide stéarique, Saveur de menthe poivrée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm) Helps to prevent and/or reduce the effects of jet lag (e.g. daytime fatigue, sleep disturbance) for people travelling by plane easterly across two or more time zones Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Forseti CanaMed Melatonin 3 mg Sublingual Tablet, Genesis CanaMed Melatonin 3 mg Sublingual Tablet, Quadrant CanaMed Melatonin 3 mg Sublingual Tablet, Trianon CanaMed Melatonin 3 mg Sublingual Tablet, Valens CanaMed Melatonin 3 mg Sublingual Tablet
- Licence holder
- CanaMed Life Sciences Inc.
- NPN or DIN-HM
- 80050078
- Status
- Active licence
- Licence date
- 10 April 2014
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80050078
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.